MedDataX Logo

Construction and Clinical Validation Study of a Prediction Model for Depression After Ischemic Stroke

NCT ID: NCT07294274

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

488 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-22

Study Completion Date

2026-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Post-stroke depression (PSD) is the most common neuropsychiatric disorder after a stroke, with an incidence rate of 20% to 60%. PSD is not only associated with higher mortality rates, poorer recovery, more obvious cognitive impairments, greater economic burdens, and lower quality of life, but also brings additional medical expenses and care pressure to families. Society also needs to bear higher medical costs. Currently, the early diagnosis of PSD is difficult, which may lead to poor prognosis after stroke. This study aims to utilize machine learning technology to integrate multi-dimensional indicators of patients with ischemic stroke, establish a risk prediction model for PSD, and assist in early, accurate, and individualized assessment of PSD risk in clinical practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-stroke Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The group of PSD

The patient was diagnosed with PSD.

Group patients based on whether they have been diagnosed with PSD.

Intervention Type DIAGNOSTIC_TEST

Group patients based on whether they have been diagnosed with PSD.

NPSD

The patient was not diagnosed with PSD.

Group patients based on whether they have been diagnosed with PSD.

Intervention Type DIAGNOSTIC_TEST

Group patients based on whether they have been diagnosed with PSD.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Group patients based on whether they have been diagnosed with PSD.

Group patients based on whether they have been diagnosed with PSD.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with acute ischemic stroke;
* Admission within 7 days of symptom onset;
* The patient and/or the family members sign a written informed consent form.

Exclusion Criteria

* Confusion of consciousness,severe cognitive impairment, etc
* Individuals with a history of depression, schizophrenia, bipolar disorder, etc;
* Individuals unable to participate in neuropsychological examinations due to hearing im pairments, lack of coordination, or neurological deficits, including se vere aphasia.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chongqing Traditional Chinese Medicine Hospital

OTHER

Sponsor Role collaborator

Min Su

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Min Su

Professor of Anesthesiology

Responsibility Role SPONSOR_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20251114

Identifier Type: -

Identifier Source: org_study_id